Skip to main content
Equibles

Northwest & Ethical Investments L.P.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 2033536 TORONTO, A6
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,222,286
+$2,367,852 QoQ
Shares Held
222,380
+260.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#43
of 238 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Northwest & Ethical Investments L.P. holds $7,782,143 across 8 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (41.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
This page 		222,380 $3,222,286
2 UTHR
UNITED THERAPEUTICS Corp
 3,156 $1,710,015
3 ZTS
Zoetis Inc.
 21,651 $1,555,840
4 TEVA
Teva Pharmaceutical Industries Ltd
 14,787 $500,983
5 ELAN
Elanco Animal Health Inc
 13,829 $340,331
6 BHC
Bausch Health Companies Inc.
 52,822 $260,412
7 TRLV
Trulieve Cannabis Corp.
 13,381 $131,535
8 HIMS
Hims & Hers Health, Inc.
 1,752 $60,741

All Filings in RDY

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,222,286 222,380
2026-03-31 $854,434 61,692